← Back to news
S

Seeking Alpha: News

OpenAI's new Codex Mac app off to a strong start, Altman says

S

Copper bounces as China aims to expand strategic inventories

S

Enterprise software stocks tumble as analysts mull growth acceleration amid AI impact

S

Nxp outlines $3.15B Q1 2026 outlook as company pivots to SDV and physical AI platforms

B

Audiocodes targets 40–50% annual VoiceAI growth and up to $255M 2026 revenue amid AI-driven momentum

B

Madison Square Garden Entertainment signals robust growth path in fiscal 2026 backed by record holiday attendance and strong concert bookings

B

Phillips 66 heads into Q4 earnings with Venezuelan crude in focus

B

Paramount CEO Ellison declined Senate hearing invite on Warner Bros. - report

B

Morgan Stanley flags near-term risk-off signal but stays overweight U.S. equities

B

Novo Nordisk crashes after 2025 results, dragging Lilly (update)

B

Equifax stock slumps after senators warn against Medicaid profiteering

B

Largest U.S. electric grid expects surge in generation outages as cold snap continues

B

Rpc outlines $150M–$180M 2026 capital spending range as it expands technology and maintains financial flexibility

B

J&J Snack Foods signals $20M annual run rate from Project Apollo as plant consolidation nears completion

B

Two Harbors signals accelerated growth with UWM merger and $400B MSR portfolio scale-up

B

Laurentian Bank of Canada PFD SHS SER 13 declares CAD 0.3873 dividend

B

AbbVie Q4 Preview: Here's what to expect

B

ETFs under pressure as PayPal Sinks more than 19%

S

FirstService Corporation raises dividend by 10.9% to $0.305

S

Nasdaq sinks -2%, U.S. stocks struggle to keep afloat despite positive Q4 results

S

PB Financial raises dividend by 1.7% to $0.61

S

Accenture in focus as UBS labels it Top Pick

S

Precious metals are caught up in a ‘memefication trade’ – Bespoke’s Paul Hickey

S

Bio-Techne Q2 2026 Earnings Preview

S

GSK Q4 2025 Earnings Preview

S

AstraZeneca denied FDA approval for subcutaneous version of lupus drug

S

Novo Nordisk’s 2026 outlook in focus as competition pressures sales

S

Fubo falls on reverse stock split; co. shares plans for ESPN reseller agreement

S

U.S. manufacturing jobs slide as tariffs, uncertainty weigh on investment

S

Rambus plunges on Q1 supply issue, but analysts expect it to continue gaining market share in 2026

S

PTC Q1 2026 Earnings Preview

S

Weatherford International Q4 2025 Earnings Preview

S

Equinor Q4 2025 Earnings Preview

S

SpaceX–xAI deal reignites IPO countdown as prediction markets take bets on the date

S

Vishay Intertechnology Q4 2025 Earnings Preview

S

Sagimet a new buy at Guggenheim on promise of MASH, acne asset

S

Flex Q3 2026 Earnings Preview

S

CDW Corporation Q4 2025 Earnings Preview

S

Eli Lilly Q4 Preview: Obesity drug momentum, Medicare tailwinds lift analysts' optimism

S

iShares 20+ Year Treasury Bond BuyWrite Strategy ETF declares monthly distribution of $0.1741

S

iShares Investment Grade Corporate Bond BuyWrite Strategy ETF declares monthly distribution of $0.2178

S

iShares Inflation Hedged Corporate Bond ETF declares monthly distribution of $0.1048

S

iShares Interest Rate Hedged Corporate Bond ETF declares monthly distribution of $0.4291

S

iShares iBonds 1-5 Year Treasury Ladder ETF declares monthly distribution of $0.0798

S

iShares iBonds 1-5 Year High Yield and Income Ladder ETF declares monthly distribution of $0.1376

S

Walmart reaches $1 trillion market value

S

Willis Towers Watson stock rallies after Q4 earnings beat

S

NXP falls on auto exposure, slow industrial recovery, gross margin pressure: analysts

S

PLTR jumps on earnings; see what SA analysts are saying

S

ManpowerGroup attracts a bull rating from Argus

S